RCS - Resolution Life Grp - Resolution Life completes $500m Tier 2 issuance

Mizuho FinancialAnnouncement

17/07/2024 17:00

For best results when printing this announcement, please click on link below:
http://newsfile.refinitiv.com/getnewsfile/v1/story?guid=urn:newsml:reuters.com:20240717:nRSQ8189Wa&default-theme=true

RNS Number : 8189W  Resolution Life Group  17 July 2024

NOT FOR RELEASE, PUBLICATION OR DISTRIBUTION TO ANY U.S. PERSON (AS DEFINED IN
REGULATIONS UNDER THE UNITED STATES SECURITIES ACT OF 1933, AS AMENDED) OR IN
OR INTO THE UNITED STATES OF AMERICA, ITS TERRITORIES AND POSSESSIONS OR IN OR
INTO ANY OTHER JURISDICTION WHERE IT IS UNLAWFUL TO RELEASE, PUBLISH OR
DISTRIBUTE THIS ANNOUNCEMENT. SEE "DISCLAIMER" BELOW.

 

Resolution Life successfully completes inaugural $500 million Tier 2 listed
debt issuance

 

·      Issuance of $500 million of 8.25% Tier 2 notes due 2031

·      Strong investor demand with peak order book exceeding $1.2
billion

·      Further strengthens the Group's capital position whilst
diversifying its investor base and sources of long-term capital

HAMILTON, BERMUDA - Resolution Life, a global life insurance group focusing on
reinsurance and the acquisition and management of portfolios of life insurance
policies, today announced the issuance of its first listed debt.

RLGH Finance Bermuda Ltd, issued $500 million of 8.25% Tier 2 notes due 2031
(the "Notes"), which are guaranteed by Resolution Life Group Holdings Ltd. The
Notes qualify as Tier 2 regulatory capital and have been assigned an
instrument rating of Baa3 by Moody's and BB+ by Fitch. Application has been
made for the Notes to be admitted to trading on the International Securities
Market of the London Stock Exchange.

The issuance of listed subordinated debt represents an important next step in
Resolution Life's strategic development, strengthening its capital position
and accessing new sources of long term capital.

Simon Woods, Group Chief Financial Officer of Resolution Life, commented:

"We are delighted with our successful debut Tier 2 issuance. The positive
investor reception reflects the cash generative nature of our business model,
our robust balance sheet and our global growth franchise. This is an important
step in the evolution of the group."

Barclays, Citi, Mizuho, Morgan Stanley, NatWest Markets, and Wells Fargo
Securities acted as Joint Lead Managers on the transaction.

ENDS

 

Notes to Editors:

About Resolution Life

Resolution Life is a global life insurance group focusing on reinsurance and
the acquisition and management of portfolios of life insurance policies. Since
its launch in 2018, the Group has deployed approximately $8 billion of debt
and equity capital in the acquisition, reinsurance, consolidation and
management of life insurance companies. As of 31 December 2023, the Group
serves the needs of over 4 million policyholders while managing approximately
$85 billion of assets. Resolution Life today has operations in Bermuda, the
U.K., the U.S., Australia and New Zealand, assisting the restructuring of the
primary life insurance industry globally.  Resolution Life provides a safe
and reliable partner for insurers by:

·    Focusing on serving existing customers, and supporting primary
insurers with new sales

·    Delivering policyholder benefits in a secure, well capitalised
environment

·    Returning capital over time to our institutional investors in the
form of a steady dividend yield

 

Visit resolutionlife.com (http://www.resolutionlife.com) for more information.

 

Media Enquiries:

Debt Investor Relations

Colin Ault                      Head of Corporate Finance

Julia van Tuyll               Head of Investor Relations

Phone:                          +44 (0)20 7661 3600

Email:
Investor.Relations@ResolutionLife.com

 

Temple Bar Advisory

Alex Child-Villiers:         +44 (0)7795 425 580

Juliette Packard:           +44 (0)7425 826161

Email:
resolution@templebaradvisory.com

 

 

Disclaimer

The distribution of this announcement may be restricted by law and any person
into whose possession this press release comes should inform themselves about
and observe any restrictions. This announcement is not directed to, and is not
intended for distribution to or use by, any person or entity in any
jurisdiction where such distribution, publication or use would be contrary to
law or regulation or which would require any registration within such
jurisdiction. This announcement is not intended to, and does not constitute,
or form part of, an offer to sell or an invitation to purchase or subscribe
for the Notes, nor shall there by any offer, solicitation or sale of the Notes
in any jurisdiction in which such offer, solicitation or sale would be
unlawful.

The Notes have not been and will not be registered under the United States
Securities Act of 1933, as amended (the "Securities Act"), or any state
securities laws, and may not be offered or sold in the United States or to, or
for the account or benefit of, U.S. persons (as defined in Regulation S under
the Securities Act).

A rating is not a recommendation to buy, sell or hold the notes and may be
subject to suspension, reduction or withdrawal at any time.

This announcement does not constitute an offer to sell or a solicitation of an
offer to buy securities.

Neither this announcement nor the offering memoranda prepared in respect of
the Notes constitutes a prospectus for the purposes of Part VI of the
Financial Services and Markets Act 2000, Regulation (EU) 2017/1129 or that
Regulation as it forms part of UK domestic law by virtue of the European Union
(Withdrawal) Act 2018 ("EUWA"), and no such prospectus has been or will be
prepared.

Manufacturer target market (UK MiFIR and EU MIFID II product governance) is
eligible counterparties and professional clients only (all appropriate
distribution channels). No key information document (KID) under Regulation
(EU) No. 1286/2014 or that Regulation as it forms part of UK domestic law by
virtue of the EUWA has been prepared as the Notes are not available to retail
investors in the European Economic Area or the United Kingdom.

This announcement does not constitute nor form a part of any offer or
solicitation to purchase or subscribe for securities in Singapore or
elsewhere. The Notes referred to herein have not been and will not be offered
or sold or be made the subject of an invitation for subscription or purchase,
whether directly or indirectly, to any person in Singapore other than (i) to
an institutional investor (as defined in Section 4A of the Securities and
Futures Act 2001 of Singapore, as modified or amended from time to time (the
"SFA")) pursuant to Section 274 of the SFA or (ii) to an accredited investor
(as defined in Section 4A of the SFA) pursuant to and in accordance with the
conditions specified in Section 275 of the SFA.

This announcement contains certain forward-looking statements regarding the
intent, belief or current expectations of Resolution Life and its management
team. Any such forward-looking statements speak only as of the date they are
made, are not guarantees of future performance and involve risks and
uncertainties. Actual events and results may differ materially from those
projected in the forward-looking statements as a result of various factors.
Resolution Life does not undertake any obligation to update any
forward-looking statements or publicly announce any updates or revisions to
any of the forward-looking statements contained herein, to reflect any change
in its expectations with regard thereto or any change in events, conditions,
circumstances or assumptions underlying such statements, except as required by
law.

This information is provided by Reach, the non-regulatory press release distribution service of RNS, part of the London Stock Exchange. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact
rns@lseg.com (mailto:rns@lseg.com)
 or visit
www.rns.com (http://www.rns.com/)
.

RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our
Privacy Policy (https://www.lseg.com/privacy-and-cookie-policy)
.   END  NRABSGDRGUBDGSR